Global Myeloma Experts Define Cure as New Approaches to Treatment Advance

Contributed by: Business Wire

Images

Business Wire associated0

Business Wire embedded0

Tags

General Health

Other Health

Health

Pharmaceutical

Oncology

International Myeloma Society

More Like This

CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 2030

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma

Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting

From Pakistan to Shanghai: A CAR-T Journey Fighting Relapsed Lymphoma

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial

PR Newswire associated0

HaemaLogiX wins "Most Promising CAR-T Pipeline in APAC" at the Asia Pacific CGT¹ Excellence Awards 2025

Ichnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001, Showing High Overall Response Rate (ORR) with Durable Responses and Favorable Safety Profile in Patients with Heavily Pretreated Multiple Myeloma